josh whiteWhat P&G Is Paying $3.8B For: How to Build a Brand a Strategic Buyer Wants
In August, L Catterton announced it had signed a definitive agreement to sell Thorne to Procter & Gamble for $3.8 billion in cash. L Catterton first invested in Thorne in October 2023, so that's less than three years of ownership, and the release says the deal is expected to close in the fourth quarter of 2026.
Every founder in supplements saw that headline. I'd guess a lot fewer of them read the release itself, and I think that's where the useful stuff is, because a seller's press release is basically a list of the things they believe the buyer paid for.
please don't make it your comp
Before anything else, Thorne isn't a comp for your seed deck. The release talks about a 40-year history of scientific expertise and practitioner relationships, and a brand with four decades behind it is a different animal than a brand with two years of Shopify data.
The Taylor Sicard consumer funding tracker makes the more useful point. Its read is that the realistic outcome for most brands is a strategic sale in the low hundreds of millions, and that every dollar you raise at a fantasy price narrows the pool of buyers who can clear it later. I agree with that, and it's the part founders tend to skip when a big number hits the news.
So the goal of this piece is to look at what made Thorne worth buying and figure out which parts a small brand can start building now, at whatever scale you're at.
what the release actually brags about
When L Catterton describes what it did with Thorne, the list is pretty specific. It recruited a leadership team and expanded marketing and commercial capabilities, put more money into science and R&D and into what it calls world-class manufacturing and quality systems, and built technology and data infrastructure so the company could serve practitioners and consumers better. On top of all that history, Thorne developed a proprietary AI wellness advisor.
Thorne's CEO, Colin Watts, says something similar in the release, crediting L Catterton for investing in the people and in capabilities across digital, AI and supply chain, and advancing the scientific rigor and quality standards.
My read, and it's only my read since I have no idea what P&G's internal model looked like, is that a big strategic buyer is mostly paying for trust that took a long time to earn, plus systems sturdy enough that the trust survives being plugged into a much bigger company. Growth matters, obviously, but plenty of fast-growing brands never find a buyer.
what an early brand can copy
You can't fake 40 years. A lot of the underlying stuff starts small though, and it's cheaper to build it in early than to bolt it on during diligence.
A trust channel you own
For Thorne the release keeps coming back to practitioners. For you it might be a group of coaches or dietitians who recommend you, or just a customer type that reorders without being asked. Whatever it is, I'd want you to be able to point to it with numbers, like what share of new customers come in through it and how they repeat compared to everyone else.
Quality systems that are written down
Strategics care a lot about not buying a recall. If your COAs and co-man audit reports live in someone's inbox, that's a problem you can fix this quarter for not much money. Get them into one place and keep them current.
Books that hold up
Diligence starts with the numbers, and the fastest way to lose a buyer's confidence is a model that doesn't tie to the books. I'd want monthly closes you trust, plus nCAC and payback by channel (payback being nCAC divided by the monthly contribution margin a customer brings in). A buyer looking at a supplement brand is going to want to see that repeat customers make the economics work, and payback by cohort is how you show it.
Data on your own customers
Thorne built an AI advisor on top of decades of practitioner and consumer insight. You don't need that, but you do need clean customer data you control, enough that you can pull cohorts and see who actually reorders.
strategics are showing up earlier
The other thing worth knowing is that big buyers don't always wait for the exit to get involved. The Taylor Sicard tracker points out that corporate venture arms like Unilever Ventures are showing up early in rounds, which it describes as effectively option-buying future acquisitions. One example it logs is Unilever Ventures leading a round in Arey, a hair longevity brand, which the tracker frames as the same investor path as Nutrafol, a brand Unilever later acquired.
I don't think that means you should go chase a corporate VC check. It does mean the people who might buy you someday may be watching a lot earlier than you think, and the first time they look at your numbers is going to shape what they think of you.
where to start
If I were a founder at a few million in revenue thinking about this, I'd start with the books. Get them closed and tied to a model with nCAC and payback by channel, and then put your quality documents in one folder. That's the version of "acquirable" you can control right now, and it's the same work that makes your next raise go smoother.
That's basically why I built the Raise-Readiness Sprint. It's a small prepaid engagement with a fixed scope and no retainer, where we get your model tied to your books and your numbers ready for the questions an investor (or someday a buyer) is going to ask. If that sounds useful, book a call and we can see if it fits.
Thorne deal details are from L Catterton's press release. The Unilever Ventures and Arey details, and the view on realistic exit sizes, are from the Taylor Sicard tracker. Opinions on what P&G valued are mine.
raise-readiness sprint
Raising in the next 3 to 9 months?
The sprint is a small prepaid engagement with a fixed scope. We do the 30 days together and you walk out with the minimum model tied to your books, a tighter deck and answers ready for the 20 questions. There's no retainer and no open-ended hours.
Not ready for a call? Grab the Raise-Ready Checklist, it's free.